Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Sell
47,155
-13,801
-23% -$4.92M 3.92% 6
2025
Q4
$20M Sell
60,956
-500
-0.8% -$159K 4.55% 8
2025
Q3
$17.3M Buy
61,456
+17,456
+40% +$5.06M 4.3% 8
2025
Q2
$12.3M Sell
44,000
-15,000
-25% -$4.25M 4.02% 8
2025
Q1
$18.4M Buy
59,000
+13,000
+28% +$3.84M 5.89% 5
2024
Q4
$12M Buy
46,000
+30,000
+188% +$8.9M 4.12% 9
2024
Q3
$5.16M Sell
16,000
-14,000
-47% -$4.58M 1.56% 21
2024
Q2
$9.37M Buy
+30,000
New +$8.81M 3.5% 10

Other funds holding AMGN

Sector Gamma AS's AMGN Position: Q1 2026 in Review

Sector Gamma AS reduced its Amgen (AMGN) stake by 23% in Q1 2026, selling an estimated $4.92M and leaving 47,155 shares worth $16.6M. The position accounts for 3.92% of the portfolio, ranked #6.

Sector Gamma AS first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $20M in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sector Gamma AS held 47,155 shares of Amgen worth $16.6M as of Q1 2026.
  • Sector Gamma AS sold 13,801 Amgen shares in Q1 2026, an estimated $4.92M.
  • Amgen made up 3.92% of Sector Gamma AS's portfolio in Q1 2026, its #6 holding.
  • Sector Gamma AS first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • Sector Gamma AS's Amgen position peaked at $20M in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.